# Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects

> **NCT03310359** · NA · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 34 (estimated)

## Conditions studied

- Metabolic Syndrome X

## Interventions

- **DIETARY_SUPPLEMENT:** Astaxanthin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03310359
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2021-03-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03310359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03310359, "Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03310359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*